Polymorphism of the promoter region and exon 1 of the CLTA4 gene in endemic pemphigus foliaceus (fogo selvagem)

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 9, 2006, Pages 1227-1232

  Pavoni, D P ^a   Cerqueira, L B ^a   Roxo, V M M S ^a   Petzl Erler, M L ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Autoimmunity; Brazilian population; CTLA4; Fogo selvagem; Genetic susceptibility; Pemphigus

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; OLIGONUCLEOTIDE;

ARTICLE; BRAZIL; CHROMOSOME 2Q; CONTROLLED STUDY; ENDEMIC DISEASE; EXON; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PEMPHIGUS FOLIACEUS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33750003708     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000900010     Document Type: Article

References (26)

1. Hans-Filho G, Aoki V, Rivitti E, Eaton DP, Lin MS, Diaz LA. Endemic pemphigus foliaceus (fogo selvagem) - 1998. The Cooperative Group on Fogo Selvagem Research. Clin Dermatol 1999; 17: 225-235.
2. Petzl-Erler ML, Santamaria J. Are HLA class II genes controlling susceptibility and resistance to Brazilian pemphigus foliaceus (fogo selvagem)? Tissue Antigens 1989; 33: 408-414.
3. Moraes ME, Fernandez-Vina M, Lazaro A, Diaz LA, Filho GH, Friedman H, et al. An epitope in the third hypervariable region of the DRB1 gone is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens 1997; 49: 35-40.
4. Pavoni DP, Roxo VM, Marquart Filho A, Petzi-Erler ML. Dissecting the associations of endemic pemphigus foliaceus (fogo selvagem) with HLA-DRB1 alleles and genotypes. Genes Immun 2003; 4: 110-116.
5. Pereira NF, Hansen JA, Lin MT, Roxo VM, Braun K, Petzl-Erler ML. Cytokine gene polymorphisms in endemic pemphigus foliaceus: a possible role for IL6 variants. Cytokine 2004; 28: 233-241.
6. Roxo VM, Pereira NF, Pavoni DP, Lin MT, Hansen JA, de O Poersch C, et al. Polymorphisms within the tumor necrosis factor and lymphotoxin-alpha genes and endemic pemphigus foliaceus - are there any associations? Tissue Antigens 2003; 62: 394-400.
7. Chikuma S, Bluestone JA. CTLA-4 and tolerance: the biochemical point of view. Immunol Res 2003; 28: 241-253.
8. Huang D, Giscombe R, Zhou Y, Pirskanen R, Lefvert AK. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol 2000; 105:69-77.
9. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ. CTLA-4 gene polymorphism at position 49 in axon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 2000; 165: 6606-6611.
10. Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2001; 2:145-152.
11. Maurer M, Loserth, S, Kolb-Maurer A, Ponath A, Wiese S, Kruse N, et al. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002; 54: 1-8.
12. Wang XB, Zhao X, Giscombe R, Lefvert AK. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 2002; 3: 233-234.
13. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
14. Vaidya B, Pearce S. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. Eur J Endocrinol 2004; 150: 619-626.
15. Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 2004; 12: 620-626.
16. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A 1998; 95: 9979-9984.
17. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 2000; 1: 170-184.
18. Bonetti A, Reunanen K, Finnila S, Koivisto K, Wilkstrom J, Sumelahti ML, et al. A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes Immun 2004; 5: 142-146.
19. Miterski B, Drynda S, Boschow G, Klein W, Oppermann J, Kekow J, et al. Complex genetic predisposition in adult and juvenile rheumatoid arthritis. BMC Genet 2004; 5: 2.
20. Schneider RF, Roessli D, Excofier L. ARLEQUIN: a software for population genetic data analysis, version 2000. [Computer program]. Department of Anthropology, University of Genève, Genève: Genetics and Biometry Laboratories; 2000.
21. Miller MP. RxC: A program for the analyses of contingency tables via the Metropolis Algorithm. Computer software distributed by the author, 1997.
22. Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991; 147:1037-1044.
23. Deichmann K, Heinzmann A, Bruggenoite E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA4 promotor. Biochem Biophys Res Commun 1996; 225: 817-818.
24. Donner H, Seidl C, Braun J, Siegmund T, Herwig J, Seifried E, et al. CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DOB or DQ2 alleles in German families. Diabetes 1998; 47: 1158-1160.
25. Gonzalez-Escribano MF, Rodriguez R, Valenzuela A, Garcia A, Garcia-Lozano JR, Nunez-Roldan A. CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 1999; 53: 296-300.
26. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 1998; 51: 563-566.